Start-up skincare company La Lumiere, LLC, creator of the innovative illuMask, the world's first wearable light therapy mask, announced today that it has secured a $20 million Series B financing. The investment included Johnson & Johnson Development Corporation (JJDC), the venture capital subsidiary of Johnson & Johnson, joining SWaN & Legend Venture Partners as institutional investors in the company. The Series B investment is a culmination of efforts over the last 12 months to drive commercialization in the U.S and continued growth.

La Lumiere was founded on bringing innovations to the market for at-home beauty treatments. As a leader in an emerging field of wearable light therapy devices, La Lumiere has two products currently on the market: one for anti-aging and the other for anti-acne. 'This was an attractive investment for us because of the incredible growth in the market for at-home beauty treatments. La Lumiere is the leader in an emerging field and the only wearable light therapy device with strong intellectual property', said Todd Klein, CIO of Swan and Legend. La Lumiere estimates the market is currently worth $800 million and is expected to reach several billion dollars over the coming decade. Additionally, LED therapy is clinically proven to dramatically improve the quality of life of its users, and La Lumiere's illuMask® makes it more accessible to consumers across the country.

'This funding will help our technologies to reach exponentially more people,' said Jay Tapper, Founder and CEO of La Lumiere, LLC and the illuMask® brand. 'We're confident in the market potential, La Lumiere's intellectual property and our numerous competitive advantages.'

La Lumiere plans to use the new capital to advance marketing and distribution, including a substantial advertising campaign for illuMask®, as well as funding their R&D pipeline of upcoming innovations. The illuMask® products were first introduced to the market in February 2014, and they are currently available in major mass market retailers, including Walmart, Target and Ulta. illuMask® has been endorsed by Lucky, Elle, Cosmopolitan, Allure, Health, Fitness and other magazines.

To learn more please visit www.illuMask.com

About La Lumiere, LLC
The company's debut technology, the illuMask®, is revolutionizing the skincare industry by bringing light therapy, or phototherapy, to the home market. Previously only available in dermatology offices and costing upwards of $250 for a 15-minute treatment, phototherapy is the process of using colored light to improve skin. The illuMask® is available in two varieties; the first uses a combination of red and infrared LED lights to combat signs of aging, and the second uses red and blue lights to fight acne. La Lumiere CEO Jay Tapper is a serial entrepreneur and inventor of the Spinbrush (the world's first battery-powered toothbrush,) Spin Pop (the world's first interactive candy,) and Stretch Armstrong (the iconic children's toy.) Available for just $30, the illuMask® offers 30 treatments of 15 minutes.